| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.66e-06 | 15 | 121 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 2.15e-06 | 5 | 121 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 1.19e-05 | 8 | 121 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 3.46e-05 | 11 | 121 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 4.59e-05 | 12 | 121 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 7.52e-05 | 14 | 121 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 7.52e-05 | 14 | 121 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 9.09e-05 | 120 | 121 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 2.17e-04 | 4 | 121 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.20e-04 | 49 | 121 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 3.60e-04 | 5 | 121 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 3.60e-04 | 5 | 121 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 5.38e-04 | 6 | 121 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 5.38e-04 | 6 | 121 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 7.50e-04 | 7 | 121 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | lipid binding | AMER1 IRX5 CEL CYP3A4 CYP3A5 RNF34 LAMC1 DYSF PLEKHN1 AR PIK3C2A TPP1 PNPLA3 MCTP2 UNC13A | 9.36e-04 | 988 | 121 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 9.96e-04 | 8 | 121 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 9.96e-04 | 8 | 121 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid binding | 9.96e-04 | 8 | 121 | 2 | GO:0035727 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 9.96e-04 | 8 | 121 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.13e-03 | 34 | 121 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.23e-03 | 35 | 121 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxygen binding | 1.45e-03 | 37 | 121 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.59e-03 | 10 | 121 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.63e-03 | 83 | 121 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 2.31e-03 | 12 | 121 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 2.72e-03 | 13 | 121 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 2.72e-03 | 13 | 121 | 2 | GO:0043208 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.26e-03 | 49 | 121 | 3 | GO:0051861 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.57e-08 | 6 | 119 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.57e-08 | 6 | 119 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.57e-08 | 6 | 119 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SOX10 UBE4B ESRP1 FRS2 FUZ LAMC1 AR BMP5 BMPR2 LRP2 LRP5 CTNND1 CSMD1 CTSH CTSZ FOXF2 FOXL1 | 1.44e-06 | 750 | 119 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | WHRN TCF7L2 IRX5 UBE4B ESRP1 FRS2 FUZ LAMC1 AR PTK2 BMP5 BMPR2 LRP2 LRP5 STK40 CTNND1 CSMD1 CTSH CTSZ FOXF2 FBXW11 | 1.11e-05 | 1269 | 119 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.28e-05 | 89 | 119 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SOX10 ESRP1 FRS2 FUZ LAMC1 AR BMP5 LRP2 LRP5 CTNND1 CSMD1 CTSH CTSZ FOXF2 | 1.35e-05 | 619 | 119 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 1.43e-05 | 26 | 119 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | genitalia development | 1.48e-05 | 54 | 119 | 5 | GO:0048806 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 1.53e-05 | 9 | 119 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.75e-05 | 94 | 119 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 1.77e-05 | 195 | 119 | 8 | GO:0030178 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.90e-05 | 258 | 119 | 9 | GO:0001763 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.04e-05 | 144 | 119 | 7 | GO:0006720 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.24e-05 | 29 | 119 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 2.94e-05 | 31 | 119 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 3.14e-05 | 154 | 119 | 7 | GO:0090090 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 3.28e-05 | 105 | 119 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 3.97e-05 | 12 | 119 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | SOX10 TRABD2A TCF7L2 AMER1 APC2 FUZ EGR1 LRP5 CTNND1 CTNND2 FBXW11 FOXL1 | 4.43e-05 | 516 | 119 | 12 | GO:0016055 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | SOX10 TRABD2A TCF7L2 AMER1 APC2 FUZ EGR1 CTNND1 CTNND2 FOXL1 | 5.49e-05 | 368 | 119 | 10 | GO:0030111 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 6.00e-05 | 37 | 119 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 6.87e-05 | 236 | 119 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 7.35e-05 | 75 | 119 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 1.31e-04 | 45 | 119 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 1.55e-04 | 47 | 119 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.66e-04 | 421 | 119 | 10 | GO:0048638 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 1.74e-04 | 344 | 119 | 9 | GO:0060070 | |
| GeneOntologyBiologicalProcess | sex differentiation | 2.06e-04 | 352 | 119 | 9 | GO:0007548 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 2.30e-04 | 52 | 119 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | developmental growth | SOX10 SOX15 FBLN5 TCF7L2 WWC3 DYSF COLQ AR PTK2 RNF157 SETDB1 BMPR2 SEMA6D STK40 UNC13A | 2.40e-04 | 911 | 119 | 15 | GO:0048589 |
| GeneOntologyBiologicalProcess | retinol metabolic process | 2.48e-04 | 53 | 119 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | growth | SOX10 SOX15 FBLN5 TCF7L2 WWC3 TSG101 DYSF COLQ AR PTK2 RNF157 SETDB1 BMPR2 SEMA6D STK40 UNC13A FOXK1 OSGIN1 | 2.51e-04 | 1235 | 119 | 18 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 2.51e-04 | 285 | 119 | 8 | GO:0060828 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 2.57e-04 | 286 | 119 | 8 | GO:0042445 | |
| GeneOntologyBiologicalProcess | epithelium development | WHRN SOX10 TCF7L2 SIPA1L3 ESRP1 FRS2 FUZ LAMC1 TSG101 AR BMP5 BMPR2 DMRT2 LRP2 LRP5 CTNND1 CSMD1 CTSH CTSZ FOXF2 | 2.71e-04 | 1469 | 119 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | mesenchyme development | 3.10e-04 | 372 | 119 | 9 | GO:0060485 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 3.24e-04 | 296 | 119 | 8 | GO:0048762 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 3.26e-04 | 5 | 119 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | demethylation | 3.47e-04 | 24 | 119 | 3 | GO:0070988 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 3.74e-04 | 106 | 119 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 3.84e-04 | 383 | 119 | 9 | GO:0048608 | |
| GeneOntologyBiologicalProcess | tube development | SOX10 FBLN5 TCF7L2 ESRP1 FUZ DYSF AR PTK2 BMP5 BMPR2 PIK3C2A LRP2 LRP5 STK40 CSMD1 CTSH CTSZ FOXF2 FOXL1 | 4.16e-04 | 1402 | 119 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | reproductive system development | 4.21e-04 | 388 | 119 | 9 | GO:0061458 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | SOX10 SOX15 FBLN5 TCF7L2 ESRP1 FRS2 LAMC1 DYSF AR PTK2 BMP5 EGR1 PDGFD LRP2 LRP5 CTSH GAREM1 | 4.77e-04 | 1190 | 119 | 17 | GO:0008284 |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.44e-04 | 115 | 119 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | regulation of growth | SOX15 TCF7L2 WWC3 TSG101 COLQ AR PTK2 RNF157 BMPR2 SEMA6D UNC13A FOXK1 OSGIN1 | 5.51e-04 | 777 | 119 | 13 | GO:0040008 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 5.89e-04 | 178 | 119 | 6 | GO:0022612 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 6.12e-04 | 118 | 119 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 6.24e-04 | 180 | 119 | 6 | GO:0120254 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 6.48e-04 | 412 | 119 | 9 | GO:0006066 | |
| GeneOntologyBiologicalProcess | branching involved in mammary gland duct morphogenesis | 6.78e-04 | 30 | 119 | 3 | GO:0060444 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 6.80e-04 | 7 | 119 | 2 | GO:0007185 | |
| GeneOntologyBiologicalProcess | mammary gland branching involved in pregnancy | 6.80e-04 | 7 | 119 | 2 | GO:0060745 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | SOX15 TCF7L2 IRX5 DAZ4 FRS2 DAZ1 AR BMP5 BMPR2 DMRT2 SEC23IP LRP2 CSMD1 DAZ3 DAZ2 FOXF2 FBXW11 | 7.24e-04 | 1235 | 119 | 17 | GO:0003006 |
| GeneOntologyBiologicalProcess | tube morphogenesis | SOX10 FBLN5 TCF7L2 ESRP1 FUZ DYSF AR PTK2 BMP5 BMPR2 PIK3C2A LRP2 LRP5 CSMD1 CTSH CTSZ | 7.43e-04 | 1125 | 119 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 7.56e-04 | 421 | 119 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TRABD2A ABCA13 DAZ4 FUZ TOGARAM1 DAZ1 TSG101 AR PTK2 SETDB1 BMP5 BMPR2 PTPRF SORBS3 LRP2 LRP5 DAZ3 DAZ2 | 8.30e-04 | 1366 | 119 | 18 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of glomerular mesangial cell proliferation | 9.03e-04 | 8 | 119 | 2 | GO:0072126 | |
| GeneOntologyBiologicalProcess | aflatoxin metabolic process | 9.03e-04 | 8 | 119 | 2 | GO:0046222 | |
| GeneOntologyBiologicalProcess | mycotoxin metabolic process | 9.03e-04 | 8 | 119 | 2 | GO:0043385 | |
| GeneOntologyBiologicalProcess | organic heteropentacyclic compound metabolic process | 9.03e-04 | 8 | 119 | 2 | GO:1901376 | |
| GeneOntologyBiologicalProcess | pattern specification process | 9.49e-04 | 526 | 119 | 10 | GO:0007389 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 9.99e-04 | 197 | 119 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 1.02e-03 | 198 | 119 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.03e-03 | 77 | 119 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | lung morphogenesis | 1.03e-03 | 77 | 119 | 4 | GO:0060425 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.08e-03 | 134 | 119 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 1.08e-03 | 134 | 119 | 5 | GO:0014910 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX10 SOX15 FBLN5 TCF7L2 WWC3 ETV3 TSG101 ERN2 AR OTUD7B SETDB1 EGR1 SETD5 SORBS3 MUC1 FOXK1 FOXF2 FBXW11 | 1.09e-03 | 1399 | 119 | 18 | GO:0045892 |
| GeneOntologyBiologicalProcess | alkaloid metabolic process | 1.16e-03 | 9 | 119 | 2 | GO:0009820 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX10 SOX15 FBLN5 TCF7L2 WWC3 ETV3 TSG101 ERN2 AR OTUD7B SETDB1 EGR1 SETD5 SORBS3 MUC1 FOXK1 FOXF2 FBXW11 | 1.22e-03 | 1413 | 119 | 18 | GO:1902679 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.28e-03 | 139 | 119 | 5 | GO:0007173 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | TCF7L2 FRS2 FUZ TSG101 AR PTK2 BMP5 PTPRF PIK3C2A PDGFD GAREM1 SORL1 | 1.28e-03 | 747 | 119 | 12 | GO:0007169 |
| GeneOntologyBiologicalProcess | negative regulation of growth | 1.29e-03 | 283 | 119 | 7 | GO:0045926 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | TCF7L2 FRS2 FUZ TSG101 ZC3H3 AR PTK2 BMP5 BMPR2 PTPRF PIK3C2A EGR1 PDGFD LRP2 GAREM1 SORL1 | 1.29e-03 | 1186 | 119 | 16 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 1.30e-03 | 82 | 119 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell migration | 1.36e-03 | 83 | 119 | 4 | GO:0014911 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation involved in kidney development | 1.44e-03 | 10 | 119 | 2 | GO:1901724 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.45e-03 | 212 | 119 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | cell junction organization | WHRN CLDN14 PKP4 LAMC1 COLQ PTK2 SYNGAP1 PTPRF SETD5 LRP5 CTNND2 BSN PCDHGC3 UNC13A | 1.47e-03 | 974 | 119 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.48e-03 | 558 | 119 | 10 | GO:0060537 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 1.53e-03 | 376 | 119 | 8 | GO:0008202 | |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 1.54e-03 | 145 | 119 | 5 | GO:0014909 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.56e-03 | 215 | 119 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.56e-03 | 215 | 119 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.58e-03 | 40 | 119 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.62e-03 | 87 | 119 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.69e-03 | 88 | 119 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 1.70e-03 | 41 | 119 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | epithelial tube branching involved in lung morphogenesis | 1.70e-03 | 41 | 119 | 3 | GO:0060441 | |
| Domain | Cyt_P450_E_grp-II | 2.37e-06 | 5 | 117 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 4.73e-06 | 6 | 117 | 3 | IPR008072 | |
| Domain | Plakophilin/d_Catenin | 8.23e-06 | 7 | 117 | 3 | IPR028435 | |
| Domain | Arm | 4.04e-05 | 31 | 117 | 4 | PF00514 | |
| Domain | Ldl_recept_b | 8.29e-05 | 14 | 117 | 3 | PF00058 | |
| Domain | LDLRB | 8.29e-05 | 14 | 117 | 3 | PS51120 | |
| Domain | LY | 1.03e-04 | 15 | 117 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.03e-04 | 15 | 117 | 3 | IPR000033 | |
| Domain | ARM_REPEAT | 1.12e-04 | 40 | 117 | 4 | PS50176 | |
| Domain | ARM | 1.12e-04 | 40 | 117 | 4 | SM00185 | |
| Domain | Armadillo | 2.12e-04 | 47 | 117 | 4 | IPR000225 | |
| Domain | C2 | 2.72e-04 | 142 | 117 | 6 | PS50004 | |
| Domain | Cyt_P450_CS | 3.38e-04 | 53 | 117 | 4 | IPR017972 | |
| Domain | - | 3.40e-04 | 148 | 117 | 6 | 2.60.40.150 | |
| Domain | CYTOCHROME_P450 | 4.47e-04 | 57 | 117 | 4 | PS00086 | |
| Domain | p450 | 4.78e-04 | 58 | 117 | 4 | PF00067 | |
| Domain | - | 5.00e-04 | 222 | 117 | 7 | 1.25.10.10 | |
| Domain | Cyt_P450 | 5.44e-04 | 60 | 117 | 4 | IPR001128 | |
| Domain | RRM_dom | 5.71e-04 | 227 | 117 | 7 | IPR000504 | |
| Domain | C2_dom | 5.86e-04 | 164 | 117 | 6 | IPR000008 | |
| Domain | RRM | 6.17e-04 | 230 | 117 | 7 | PS50102 | |
| Domain | - | 8.74e-04 | 244 | 117 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.21e-03 | 258 | 117 | 7 | IPR012677 | |
| Domain | C2 | 1.41e-03 | 131 | 117 | 5 | PF00168 | |
| Domain | ARM-like | 1.57e-03 | 270 | 117 | 7 | IPR011989 | |
| Domain | Pept_asp_AS | 1.69e-03 | 10 | 117 | 2 | IPR025661 | |
| Domain | C2 | 1.71e-03 | 137 | 117 | 5 | SM00239 | |
| Domain | - | 1.86e-03 | 39 | 117 | 3 | 2.120.10.30 | |
| Domain | RRM_1 | 1.99e-03 | 208 | 117 | 6 | PF00076 | |
| Domain | LDLR_class-A_CS | 2.00e-03 | 40 | 117 | 3 | IPR023415 | |
| Domain | RRM | 2.46e-03 | 217 | 117 | 6 | SM00360 | |
| Domain | Cyt_P450_E_grp-I | 2.81e-03 | 45 | 117 | 3 | IPR002401 | |
| Domain | Ldl_recept_a | 2.81e-03 | 45 | 117 | 3 | PF00057 | |
| Domain | OTU | 2.90e-03 | 13 | 117 | 2 | PF02338 | |
| Domain | Pept_C1 | 2.90e-03 | 13 | 117 | 2 | SM00645 | |
| Domain | Peptidase_C1A_C | 2.90e-03 | 13 | 117 | 2 | IPR000668 | |
| Domain | Peptidase_C1 | 2.90e-03 | 13 | 117 | 2 | PF00112 | |
| Domain | Peptidase_C1A | 2.90e-03 | 13 | 117 | 2 | IPR013128 | |
| Domain | TF_fork_head_CS_2 | 2.99e-03 | 46 | 117 | 3 | IPR030456 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.99e-03 | 46 | 117 | 3 | IPR011042 | |
| Domain | - | 2.99e-03 | 46 | 117 | 3 | 4.10.400.10 | |
| Domain | TF_fork_head_CS_1 | 3.18e-03 | 47 | 117 | 3 | IPR018122 | |
| Domain | LDLRA_1 | 3.38e-03 | 48 | 117 | 3 | PS01209 | |
| Domain | FH | 3.58e-03 | 49 | 117 | 3 | SM00339 | |
| Domain | CUB | 3.58e-03 | 49 | 117 | 3 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 3.58e-03 | 49 | 117 | 3 | IPR002172 | |
| Domain | LDLa | 3.58e-03 | 49 | 117 | 3 | SM00192 | |
| Domain | FORK_HEAD_1 | 3.58e-03 | 49 | 117 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 3.58e-03 | 49 | 117 | 3 | PS00658 | |
| Domain | Fork_head_dom | 3.58e-03 | 49 | 117 | 3 | IPR001766 | |
| Domain | LDLRA_2 | 3.58e-03 | 49 | 117 | 3 | PS50068 | |
| Domain | FORK_HEAD_3 | 3.58e-03 | 49 | 117 | 3 | PS50039 | |
| Domain | Forkhead | 3.58e-03 | 49 | 117 | 3 | PF00250 | |
| Domain | CUB | 3.79e-03 | 50 | 117 | 3 | SM00042 | |
| Domain | OTU | 3.87e-03 | 15 | 117 | 2 | PS50802 | |
| Domain | OTU_dom | 3.87e-03 | 15 | 117 | 2 | IPR003323 | |
| Domain | - | 4.24e-03 | 52 | 117 | 3 | 2.60.120.290 | |
| Domain | CUB | 4.47e-03 | 53 | 117 | 3 | PS01180 | |
| Domain | HMG_box | 4.47e-03 | 53 | 117 | 3 | PF00505 | |
| Domain | HMG_BOX_2 | 4.71e-03 | 54 | 117 | 3 | PS50118 | |
| Domain | HMG | 4.71e-03 | 54 | 117 | 3 | SM00398 | |
| Domain | - | 4.96e-03 | 55 | 117 | 3 | 1.10.30.10 | |
| Domain | CUB_dom | 5.48e-03 | 57 | 117 | 3 | IPR000859 | |
| Domain | - | 5.75e-03 | 58 | 117 | 3 | 1.10.630.10 | |
| Pathway | WP_OVARIAN_INFERTILITY | 2.50e-06 | 35 | 89 | 5 | MM15948 | |
| Pubmed | 2.72e-11 | 8 | 122 | 5 | 10823932 | ||
| Pubmed | 1.44e-10 | 4 | 122 | 4 | 7670487 | ||
| Pubmed | 1.44e-10 | 4 | 122 | 4 | 11694340 | ||
| Pubmed | 1.44e-10 | 4 | 122 | 4 | 9321470 | ||
| Pubmed | 1.44e-10 | 4 | 122 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.44e-10 | 4 | 122 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.44e-10 | 4 | 122 | 4 | 11688365 | |
| Pubmed | 1.44e-10 | 4 | 122 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.44e-10 | 4 | 122 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.44e-10 | 4 | 122 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.44e-10 | 4 | 122 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.44e-10 | 4 | 122 | 4 | 11095434 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.44e-10 | 4 | 122 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.44e-10 | 4 | 122 | 4 | 16963411 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 23579190 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 7.19e-10 | 5 | 122 | 4 | 8679003 | |
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 7.19e-10 | 5 | 122 | 4 | 17416365 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 22293198 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 7.19e-10 | 5 | 122 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 7.19e-10 | 5 | 122 | 4 | 8968756 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 7.19e-10 | 5 | 122 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 7.19e-10 | 5 | 122 | 4 | 26411291 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 7.19e-10 | 5 | 122 | 4 | 14648873 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 8896558 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 7.19e-10 | 5 | 122 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 7.19e-10 | 5 | 122 | 4 | 9288969 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 7.19e-10 | 5 | 122 | 4 | 10903443 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 7.19e-10 | 5 | 122 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 7.19e-10 | 5 | 122 | 4 | 8845845 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 7.19e-10 | 5 | 122 | 4 | 19783541 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 17761180 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 7.19e-10 | 5 | 122 | 4 | 12200456 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 11514340 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 7.19e-10 | 5 | 122 | 4 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 7.19e-10 | 5 | 122 | 4 | 23223451 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 11804965 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 21270429 | ||
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 8661148 | ||
| Pubmed | 1.43e-09 | 15 | 122 | 5 | 35772791 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.15e-09 | 6 | 122 | 4 | 18452650 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.15e-09 | 6 | 122 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.15e-09 | 6 | 122 | 4 | 31355046 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 20157580 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.15e-09 | 6 | 122 | 4 | 26077710 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 17526644 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.15e-09 | 6 | 122 | 4 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.15e-09 | 6 | 122 | 4 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.15e-09 | 6 | 122 | 4 | 23417416 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 32170089 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 16278232 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.15e-09 | 6 | 122 | 4 | 16001084 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.15e-09 | 6 | 122 | 4 | 1869307 | |
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 11390979 | ||
| Pubmed | 2.15e-09 | 6 | 122 | 4 | 27632217 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 15081113 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 22699423 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 5.00e-09 | 7 | 122 | 4 | 16946704 | |
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 10857750 | ||
| Pubmed | 5.00e-09 | 7 | 122 | 4 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 5.00e-09 | 7 | 122 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 5.00e-09 | 7 | 122 | 4 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 9.98e-09 | 8 | 122 | 4 | 23204224 | |
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 29883445 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 11869379 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 9.98e-09 | 8 | 122 | 4 | 32339196 | |
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 33749946 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 22621333 | ||
| Pubmed | 9.98e-09 | 8 | 122 | 4 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.79e-08 | 9 | 122 | 4 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.79e-08 | 9 | 122 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.79e-08 | 9 | 122 | 4 | 19695304 | |
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 28235998 | ||
| Pubmed | 1.79e-08 | 9 | 122 | 4 | 20159962 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 2.98e-08 | 10 | 122 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 2.98e-08 | 10 | 122 | 4 | 38433229 | |
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 23810942 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 12837688 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 10601091 | ||
| Pubmed | 2.98e-08 | 10 | 122 | 4 | 9922113 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 19801957 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 20621111 | ||
| Pubmed | High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. | 4.21e-08 | 3 | 122 | 3 | 11870237 | |
| Interaction | CTNNB1 interactions | BOC SOX10 TCF7L2 AMER1 PKP4 SIPA1L3 APC2 AR PTK2 OTUD7B SYNGAP1 PTPRF EGR1 FBXO42 LRP5 CTNND1 CTNND2 MUC1 USP6NL NXF1 FBXW11 | 6.59e-07 | 1009 | 122 | 21 | int:CTNNB1 |
| Interaction | NTN5 interactions | 1.24e-05 | 24 | 122 | 4 | int:NTN5 | |
| Interaction | RNF10 interactions | 1.47e-05 | 87 | 122 | 6 | int:RNF10 | |
| Interaction | NFIB interactions | 2.54e-05 | 142 | 122 | 7 | int:NFIB | |
| Interaction | ARID2 interactions | 4.09e-05 | 153 | 122 | 7 | int:ARID2 | |
| Interaction | ETV5 interactions | 4.57e-05 | 33 | 122 | 4 | int:ETV5 | |
| Interaction | CYP3A5 interactions | 4.58e-05 | 12 | 122 | 3 | int:CYP3A5 | |
| Interaction | FBLN5 interactions | 5.23e-05 | 159 | 122 | 7 | int:FBLN5 | |
| Cytoband | Yq11.223 | 1.15e-04 | 93 | 122 | 4 | Yq11.223 | |
| Cytoband | 7q21.1 | 1.94e-04 | 8 | 122 | 2 | 7q21.1 | |
| GeneFamily | Cytochrome P450 family 3 | 5.92e-06 | 8 | 87 | 3 | 1002 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.35e-05 | 43 | 87 | 4 | 409 | |
| GeneFamily | RNA binding motif containing | 5.69e-04 | 213 | 87 | 6 | 725 | |
| GeneFamily | Forkhead boxes | 1.16e-03 | 43 | 87 | 3 | 508 | |
| GeneFamily | Low density lipoprotein receptors | 1.72e-03 | 13 | 87 | 2 | 634 | |
| GeneFamily | Cathepsins | 2.31e-03 | 15 | 87 | 2 | 470 | |
| GeneFamily | OTU domain containing | 2.97e-03 | 17 | 87 | 2 | 669 | |
| GeneFamily | SRY-boxes | 3.71e-03 | 19 | 87 | 2 | 757 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 4.97e-03 | 22 | 87 | 2 | 464 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 2.15e-07 | 12 | 122 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 2.15e-07 | 12 | 122 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 3.69e-06 | 23 | 122 | 4 | MM1293 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SOX15 FBLN5 CYP3A4 DAZ4 DAZ1 ATAD2 AR NUAK2 DLAT CTNND2 DAZ3 DAZ2 MUC1 PCDHGC3 GAREM1 OSGIN1 | 5.09e-06 | 909 | 122 | 16 | M41018 |
| Coexpression | MATZUK_SPERMATOGONIA | 1.28e-05 | 31 | 122 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.65e-05 | 33 | 122 | 4 | MM701 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | BOC TCF7L2 RSPH4A COLQ CSMD3 TNRC18 EGR1 LRP2 CTNND2 PHYHIPL | 4.07e-05 | 439 | 122 | 10 | M39054 |
| Coexpression | PEREZ_TP63_TARGETS | 4.51e-05 | 356 | 122 | 9 | M10761 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 7.54e-05 | 93 | 122 | 5 | MM1185 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-09 | 179 | 122 | 9 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-09 | 179 | 122 | 9 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-09 | 182 | 122 | 9 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-09 | 182 | 122 | 9 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-09 | 182 | 122 | 9 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.04e-08 | 192 | 122 | 8 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.52e-07 | 170 | 122 | 7 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 5.49e-07 | 175 | 122 | 7 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.39e-07 | 179 | 122 | 7 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 7.15e-07 | 182 | 122 | 7 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.41e-07 | 183 | 122 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.27e-07 | 186 | 122 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.27e-07 | 186 | 122 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.88e-07 | 188 | 122 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.20e-07 | 189 | 122 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.53e-07 | 190 | 122 | 7 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-06 | 192 | 122 | 7 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-06 | 192 | 122 | 7 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.06e-06 | 193 | 122 | 7 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 194 | 122 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 194 | 122 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | (7)_Epithelial-B_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.17e-06 | 196 | 122 | 7 | 345d4cc062b43bca9d506fbf23363469a9ba496f | |
| ToppCell | 11.5-Distal-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.21e-06 | 197 | 122 | 7 | ae9505ae7e6c5e8c280f9bfb1ba79ab5bd8895e3 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-06 | 199 | 122 | 7 | debdd7dba774d9ccff7effc3f4c132393d203dfa | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.34e-06 | 200 | 122 | 7 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.34e-06 | 200 | 122 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 200 | 122 | 7 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-06 | 160 | 122 | 6 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-06 | 160 | 122 | 6 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.44e-06 | 95 | 122 | 5 | 0ac6cba7e0ed6083f777287f39a871461fa1bca4 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.44e-06 | 95 | 122 | 5 | 3d6b97576ce4e7a3e495cbc7246ea8c0b2a386f7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-06 | 167 | 122 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 6.77e-06 | 167 | 122 | 6 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 175 | 122 | 6 | 9d082ba0e350162aa6e71b668be074b12a27c7ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-06 | 175 | 122 | 6 | f641f34b52aec5d047430a6f9d026e915da6c11d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-05 | 179 | 122 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 181 | 122 | 6 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 181 | 122 | 6 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 181 | 122 | 6 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 185 | 122 | 6 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-05 | 186 | 122 | 6 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 186 | 122 | 6 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 186 | 122 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 187 | 122 | 6 | 380c3e0bc73b266718893a3b3ca207ce5fd31883 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 187 | 122 | 6 | 5b3c3c6421efd25c740ae121968b5520bbdc07b2 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 187 | 122 | 6 | 796046ff066a9c3847faa9bf1f8beccd956c01f7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 188 | 122 | 6 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 189 | 122 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.37e-05 | 189 | 122 | 6 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-05 | 190 | 122 | 6 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PND07-Epithelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-05 | 190 | 122 | 6 | e3a2c8b637f60c963520dffe99c526809d818cab | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 190 | 122 | 6 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-05 | 191 | 122 | 6 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 122 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.45e-05 | 191 | 122 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-05 | 191 | 122 | 6 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-05 | 191 | 122 | 6 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-05 | 191 | 122 | 6 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 1.45e-05 | 191 | 122 | 6 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-05 | 191 | 122 | 6 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-05 | 191 | 122 | 6 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.45e-05 | 191 | 122 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 192 | 122 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 193 | 122 | 6 | 8e934f127bc763e905c788beabfa867bd559b682 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.54e-05 | 193 | 122 | 6 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.54e-05 | 193 | 122 | 6 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 194 | 122 | 6 | c011cd59bb4ca4134331cba0f5d73bdbd7011d64 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 122 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 194 | 122 | 6 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-05 | 195 | 122 | 6 | 5276e874615823bb00e20ff160692e0946d7d400 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 195 | 122 | 6 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 195 | 122 | 6 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 195 | 122 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.68e-05 | 196 | 122 | 6 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 197 | 122 | 6 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.73e-05 | 197 | 122 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.73e-05 | 197 | 122 | 6 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-05 | 197 | 122 | 6 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.73e-05 | 197 | 122 | 6 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-05 | 197 | 122 | 6 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-05 | 197 | 122 | 6 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | 11.5-Airway-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 1.73e-05 | 197 | 122 | 6 | e671af1b69566d97afe97f1a959a07b6f4c05620 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.78e-05 | 198 | 122 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-05 | 198 | 122 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-05 | 198 | 122 | 6 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.78e-05 | 198 | 122 | 6 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 199 | 122 | 6 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-05 | 199 | 122 | 6 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.83e-05 | 199 | 122 | 6 | af664e0d41a889a75dbf6cf0d50acd26f5ab3a3a | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.83e-05 | 199 | 122 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 199 | 122 | 6 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.83e-05 | 199 | 122 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 199 | 122 | 6 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-05 | 199 | 122 | 6 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 200 | 122 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.93e-05 | 119 | 122 | 5 | ec3af1253f03b3ec403f73243237acf08ad56789 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-05 | 137 | 122 | 5 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.92e-05 | 138 | 122 | 5 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 147 | 122 | 5 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| Computational | Neighborhood of PTPRD | 3.55e-05 | 58 | 70 | 5 | GCM_PTPRD | |
| Drug | desmethylazelastine | 1.60e-10 | 16 | 122 | 6 | CID000162558 | |
| Drug | boron trichloride | 1.17e-08 | 6 | 122 | 4 | CID000025135 | |
| Drug | AZFd | 1.27e-07 | 23 | 122 | 5 | CID000196489 | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.09e-06 | 195 | 122 | 9 | 6522_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.24e-06 | 198 | 122 | 9 | 6261_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | CLDN14 TCF7L2 SIPA1L3 SETDB1 PTPRF SEC23IP SORBS3 MUC1 ALG13 | 1.29e-06 | 199 | 122 | 9 | 1960_DN |
| Drug | Fenthion | 2.27e-06 | 18 | 122 | 4 | ctd:D005284 | |
| Drug | dazmegrel | 2.86e-06 | 19 | 122 | 4 | CID000053555 | |
| Drug | YM 026 | 2.86e-06 | 19 | 122 | 4 | CID000004443 | |
| Drug | Alfentanil | 2.97e-06 | 6 | 122 | 3 | ctd:D015760 | |
| Drug | dansylaziridine | 6.42e-06 | 23 | 122 | 4 | CID000104008 | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 3886_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A | 1.13e-05 | 197 | 122 | 8 | 2545_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 2724_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A | 1.17e-05 | 198 | 122 | 8 | 2398_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.22e-05 | 199 | 122 | 8 | 6214_DN | |
| Drug | benzotriazine | 1.23e-05 | 9 | 122 | 3 | CID011018899 | |
| Drug | S 840 | 1.23e-05 | 9 | 122 | 3 | CID000096338 | |
| Drug | azafagomine | 1.36e-05 | 57 | 122 | 5 | CID011957435 | |
| Drug | chlornitrofen | 1.75e-05 | 10 | 122 | 3 | CID000015788 | |
| Drug | 4-hydroxymidazolam | 1.75e-05 | 10 | 122 | 3 | CID000124449 | |
| Drug | d-gluconhydroximo-1,5-lactam | 2.21e-05 | 31 | 122 | 4 | CID000003479 | |
| Drug | s-collidine | 2.40e-05 | 11 | 122 | 3 | CID000007953 | |
| Drug | Troleandomycin | 2.40e-05 | 11 | 122 | 3 | ctd:D014217 | |
| Drug | Ticalopride | 2.40e-05 | 11 | 122 | 3 | CID000216236 | |
| Drug | vitamin E | BOC SOX10 CYP3A4 CYP3A5 AR BMP5 PIK3C2A LRP2 LRP5 PNPLA3 SORL1 | 2.59e-05 | 441 | 122 | 11 | CID000002116 |
| Drug | kt S | 2.80e-05 | 66 | 122 | 5 | CID006399216 | |
| Drug | 1-naphthol | 2.85e-05 | 33 | 122 | 4 | ctd:C029350 | |
| Drug | 4-hydroxymidazolam | 2.85e-05 | 2 | 122 | 2 | ctd:C042940 | |
| Drug | norverapamil | 2.85e-05 | 2 | 122 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 2.85e-05 | 2 | 122 | 2 | CID000520660 | |
| Drug | notopterol | 2.85e-05 | 2 | 122 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 2.85e-05 | 2 | 122 | 2 | ctd:C114289 | |
| Drug | 6 beta-hydroxytestosterone | 2.85e-05 | 2 | 122 | 2 | ctd:C025591 | |
| Drug | 7-vinyloxycoumarin | 2.85e-05 | 2 | 122 | 2 | CID000129300 | |
| Drug | CQA 206-291 | 2.85e-05 | 2 | 122 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 2.85e-05 | 2 | 122 | 2 | ctd:C009252 | |
| Drug | Vistar | 4.05e-05 | 36 | 122 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 4.05e-05 | 36 | 122 | 4 | CID000001649 | |
| Drug | skatole | 4.52e-05 | 37 | 122 | 4 | CID000006736 | |
| Drug | azelastine | 4.88e-05 | 74 | 122 | 5 | CID000002267 | |
| Drug | p11-13 | 5.20e-05 | 75 | 122 | 5 | CID000015759 | |
| Drug | propionanilide | 5.23e-05 | 14 | 122 | 3 | CID000012107 | |
| Drug | 7-BFC | 5.23e-05 | 14 | 122 | 3 | CID000848780 | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.74e-05 | 182 | 122 | 7 | 848_UP | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 6.15e-05 | 184 | 122 | 7 | 2686_UP | |
| Drug | lipoyllysine | 6.52e-05 | 15 | 122 | 3 | CID000161338 | |
| Drug | methylenedinitramine | 7.50e-05 | 42 | 122 | 4 | CID000026524 | |
| Drug | molybdenum disulfide | 8.24e-05 | 43 | 122 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 8.24e-05 | 43 | 122 | 4 | CID000072194 | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 6400_DN | |
| Drug | erythralosamine | 8.51e-05 | 3 | 122 | 2 | CID000352196 | |
| Drug | 3-methoxymorphinan | 8.51e-05 | 3 | 122 | 2 | ctd:C028657 | |
| Drug | dechloroethylcyclophosphamide | 8.51e-05 | 3 | 122 | 2 | ctd:C064445 | |
| Drug | 6 beta-hydroxydexamethasone | 8.51e-05 | 3 | 122 | 2 | CID000063050 | |
| Drug | territrem C | 8.51e-05 | 3 | 122 | 2 | CID000160306 | |
| Drug | 17-hydroxypregnenolone sulfate | 8.51e-05 | 3 | 122 | 2 | CID000152971 | |
| Drug | D-CW | 8.51e-05 | 3 | 122 | 2 | CID000004277 | |
| Drug | 1-hydroxymethylmidazolam | 8.51e-05 | 3 | 122 | 2 | ctd:C040081 | |
| Drug | muscone | 8.51e-05 | 3 | 122 | 2 | CID000010947 | |
| Drug | N-acetyl-S-pentachloro-1,3-butadienylcysteine | 8.51e-05 | 3 | 122 | 2 | ctd:C049739 | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 6710_UP | |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 7399_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; HL60; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 2524_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 2900_DN | |
| Drug | NS-398; Down 200; 10uM; PC3; HT_HG-U133A | 8.86e-05 | 195 | 122 | 7 | 6892_DN | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.86e-05 | 195 | 122 | 7 | 953_DN | |
| Drug | 5 alpha-androstane | 8.96e-05 | 84 | 122 | 5 | CID000094144 | |
| Drug | propham | 9.02e-05 | 44 | 122 | 4 | CID000024685 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 1326_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 3461_UP | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 2443_DN | |
| Drug | Epi Lovastatin | 9.44e-05 | 341 | 122 | 9 | CID000003962 | |
| Drug | Ciprofibrate [52214-84-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 3561_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; HL60; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 1845_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 6240_DN | |
| Drug | noralfentanil | 9.66e-05 | 17 | 122 | 3 | CID000162172 | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 7166_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 4301_UP | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2633_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 6208_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 3059_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2170_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2217_DN | |
| Drug | Cefotiam hydrochloride; Down 200; 7.2uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2458_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2990_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 3311_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 9.75e-05 | 198 | 122 | 7 | 426_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; HL60; HT_HG-U133A | 9.75e-05 | 198 | 122 | 7 | 2345_UP | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 2404_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 2725_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; HL60; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 6148_DN | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.04e-04 | 200 | 122 | 7 | 4824_DN | |
| Drug | Glucocorticoids | 1.08e-04 | 46 | 122 | 4 | ctd:D005938 | |
| Drug | Dehydroepiandrosterone | 1.14e-04 | 141 | 122 | 6 | ctd:D003687 | |
| Drug | aflatoxin | 1.15e-04 | 18 | 122 | 3 | CID000014421 | |
| Drug | Azamulinum | 1.15e-04 | 18 | 122 | 3 | CID003086060 | |
| Drug | AC1L1SX8 | 1.15e-04 | 18 | 122 | 3 | CID000060278 | |
| Drug | carbosulfan | 1.18e-04 | 89 | 122 | 5 | CID000041384 | |
| Drug | rabeprazole | 1.37e-04 | 19 | 122 | 3 | CID000005029 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.86e-08 | 8 | 121 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.86e-08 | 8 | 121 | 4 | C1507149 | |
| Disease | tacrolimus measurement | 2.68e-07 | 4 | 121 | 3 | EFO_0008458 | |
| Disease | Colorectal Carcinoma | ERICH1 BOC TCF7L2 ABCA13 APC2 LAMC1 CSMD3 TFG PDGFD LRP2 CTNND2 CTSH SORL1 | 6.52e-06 | 702 | 121 | 13 | C0009402 |
| Disease | Prostatic Neoplasms | FBLN5 CYP3A4 CYP3A5 CDK12 ETV3 LAMC1 AR SETDB1 EGR1 PDP1 TPP1 LRP2 | 9.11e-06 | 616 | 121 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | FBLN5 CYP3A4 CYP3A5 CDK12 ETV3 LAMC1 AR SETDB1 EGR1 PDP1 TPP1 LRP2 | 9.11e-06 | 616 | 121 | 12 | C0376358 |
| Disease | cerebrospinal fluid clusterin measurement | 1.28e-05 | 35 | 121 | 4 | EFO_0007657 | |
| Disease | testosterone measurement | DXO SOX15 CYP3A7 AMER1 QPCTL CYP3A4 CSMD3 AR BMP5 ARID1B SEMA6D PTPRF EGR1 SEC23IP LRP5 PNPLA3 OSGIN1 | 1.82e-05 | 1275 | 121 | 17 | EFO_0004908 |
| Disease | urate measurement | CLDN14 CYP3A7 TCF7L2 CYP3A4 ESRP1 DYSF FRMD4B BMP5 BMPR2 PTPRF LRP2 PNPLA3 MUC1 FOXK1 | 1.89e-05 | 895 | 121 | 14 | EFO_0004531 |
| Disease | free androgen index | 2.49e-05 | 374 | 121 | 9 | EFO_0007005 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.62e-05 | 16 | 121 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.62e-05 | 16 | 121 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.62e-05 | 16 | 121 | 3 | 415000 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.99e-05 | 152 | 121 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.16e-05 | 93 | 121 | 5 | C1535926 | |
| Disease | uric acid measurement | CLDN14 TCF7L2 CEL SIPA1L3 AR BMPR2 LRP2 PNPLA3 MUC1 FOXK1 GAREM1 | 4.42e-05 | 610 | 121 | 11 | EFO_0004761 |
| Disease | metabolonic lactone sulfate measurement | 6.21e-05 | 19 | 121 | 3 | EFO_0800659 | |
| Disease | hepatocellular carcinoma, non-alcoholic steatohepatitis | 9.95e-05 | 4 | 121 | 2 | EFO_0000182, EFO_1001249 | |
| Disease | estrone conjugate measurement | 9.95e-05 | 4 | 121 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 1.65e-04 | 5 | 121 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 1.65e-04 | 5 | 121 | 2 | EFO_0800569 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 2.47e-04 | 6 | 121 | 2 | EFO_0021119 | |
| Disease | pyruvate decarboxylase deficiency (is_implicated_in) | 2.47e-04 | 6 | 121 | 2 | DOID:3649 (is_implicated_in) | |
| Disease | leiomyoma (is_implicated_in) | 2.47e-04 | 6 | 121 | 2 | DOID:127 (is_implicated_in) | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 2.47e-04 | 6 | 121 | 2 | EFO_0800294 | |
| Disease | alcohol use disorder measurement | 2.61e-04 | 214 | 121 | 6 | EFO_0009458 | |
| Disease | Abnormality of the eye | 3.46e-04 | 7 | 121 | 2 | C4316870 | |
| Disease | X-24574 measurement | 3.46e-04 | 7 | 121 | 2 | EFO_0800897 | |
| Disease | forced expiratory volume | BOC CYP3A7 CYP3A4 CDK12 FRS2 DEFB135 DMRT2 LRP5 CTNND2 MUC1 GAREM1 | 4.14e-04 | 789 | 121 | 11 | EFO_0004314 |
| Disease | colorectal cancer, colorectal adenoma | 4.18e-04 | 152 | 121 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | Paroxysmal atrial fibrillation | 4.70e-04 | 156 | 121 | 5 | C0235480 | |
| Disease | prostate cancer (is_marker_for) | 4.70e-04 | 156 | 121 | 5 | DOID:10283 (is_marker_for) | |
| Disease | familial atrial fibrillation | 4.70e-04 | 156 | 121 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.70e-04 | 156 | 121 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 5.28e-04 | 160 | 121 | 5 | C0004238 | |
| Disease | urinary metabolite measurement | 5.35e-04 | 245 | 121 | 6 | EFO_0005116 | |
| Disease | Alzheimer disease, educational attainment | 5.58e-04 | 247 | 121 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 5.89e-04 | 9 | 121 | 2 | EFO_0800278 | |
| Disease | Fuchs endothelial corneal dystrophy | 7.35e-04 | 10 | 121 | 2 | Orphanet_98974 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 7.35e-04 | 10 | 121 | 2 | EFO_0022090 | |
| Disease | Joubert syndrome (is_implicated_in) | 7.35e-04 | 10 | 121 | 2 | DOID:0050777 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 7.35e-04 | 10 | 121 | 2 | EFO_0800289 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 8.95e-04 | 11 | 121 | 2 | EFO_0801531 | |
| Disease | Sensory hearing loss | 8.95e-04 | 11 | 121 | 2 | C1691779 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 8.95e-04 | 11 | 121 | 2 | EFO_0800295 | |
| Disease | Schizophrenia | SOX10 TCF7L2 CYP3A4 CYP3A5 ABCA13 SYNGAP1 SETDB1 LRP2 CTNND2 CSMD1 MCTP2 | 1.04e-03 | 883 | 121 | 11 | C0036341 |
| Disease | methionine sulfone measurement | 1.07e-03 | 12 | 121 | 2 | EFO_0800072 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.07e-03 | 12 | 121 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0800284 | |
| Disease | intelligence, self reported educational attainment | 1.40e-03 | 117 | 121 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | X-21470 measurement | 1.47e-03 | 14 | 121 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.47e-03 | 14 | 121 | 2 | EFO_0800283 | |
| Disease | neuroimaging measurement | DXO TCF7L2 RNF34 LAMC1 DYSF FRMD4B PTK2 OTUD7B DENND4B PDGFD TMC5 FOXL1 | 1.50e-03 | 1069 | 121 | 12 | EFO_0004346 |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.69e-03 | 15 | 121 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 1.93e-03 | 16 | 121 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.93e-03 | 16 | 121 | 2 | EFO_0800305 | |
| Disease | mood instability measurement | 1.94e-03 | 128 | 121 | 4 | EFO_0008475 | |
| Disease | phosphatidylcholine 40:6 measurement | 2.18e-03 | 17 | 121 | 2 | EFO_0010389 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.23e-03 | 133 | 121 | 4 | EFO_0010092 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 2.34e-03 | 64 | 121 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | susceptibility to cold sores measurement | 2.44e-03 | 65 | 121 | 3 | EFO_0008402 | |
| Disease | ischemia (biomarker_via_orthology) | 2.44e-03 | 18 | 121 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | cortical thickness change measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0021501 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 2.44e-03 | 18 | 121 | 2 | EFO_0800288 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 2.44e-03 | 18 | 121 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | Intellectual Disability | 2.51e-03 | 447 | 121 | 7 | C3714756 | |
| Disease | osteoporosis (implicated_via_orthology) | 2.72e-03 | 19 | 121 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | etiocholanolone glucuronide measurement | 2.72e-03 | 19 | 121 | 2 | EFO_0800362 | |
| Disease | schizophrenia (implicated_via_orthology) | 2.78e-03 | 68 | 121 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | dehydroepiandrosterone sulphate measurement | 2.78e-03 | 68 | 121 | 3 | EFO_0007001 | |
| Disease | smoking behavior | 2.88e-03 | 341 | 121 | 6 | EFO_0004318 | |
| Disease | androsterone glucuronide measurement | 3.02e-03 | 20 | 121 | 2 | EFO_0800317 | |
| Disease | Hereditary hearing loss and deafness | 3.12e-03 | 146 | 121 | 4 | cv:C0236038 | |
| Disease | facial morphology measurement | 3.16e-03 | 466 | 121 | 7 | EFO_0007841 | |
| Disease | amyloid-beta measurement | 3.51e-03 | 355 | 121 | 6 | EFO_0005194 | |
| Disease | X-24947 measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0021115 | |
| Disease | coronary artery disease | DXO TCF7L2 CEL CDK12 LAMC1 OTUD7B PNPLA3 BSN MUC1 MCTP2 UNC13A FOXL1 | 3.71e-03 | 1194 | 121 | 12 | EFO_0001645 |
| Disease | Sensorineural Hearing Loss (disorder) | 3.99e-03 | 23 | 121 | 2 | C0018784 | |
| Disease | C-reactive protein measurement | CYP3A7 TCF7L2 CEL UBE4B CYP3A4 DEFB135 BMPR2 PTPRF SETD5 BSN SRSF9 OSGIN1 | 4.02e-03 | 1206 | 121 | 12 | EFO_0004458 |
| Disease | diffuse plaque measurement | TCF7L2 ABCA13 PKP4 CSMD3 TMEM132B FRMD4B RNF157 SEMA6D ABLIM2 | 4.09e-03 | 758 | 121 | 9 | EFO_0010699 |
| Disease | Lung diseases | 4.09e-03 | 78 | 121 | 3 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RPSYRAEQYPGSPDS | 1176 | Q99569 | |
| YSVRPPPLGSRESYS | 226 | Q9UPW8 | |
| RRLYTASGPPEGYVP | 66 | Q86X53 | |
| SAYGKLYRGPTRVPP | 1466 | Q9NYV4 | |
| LYRFPGKPPTYVTDN | 316 | Q9NP73 | |
| SGRILSPGYPAPYDN | 1286 | Q96PZ7 | |
| ESSGRILSPGYPFPY | 1421 | Q7Z407 | |
| GRSTYPRPHEYLSPA | 46 | Q9UBR2 | |
| IDPYIYTPFGTGPRN | 426 | P20815 | |
| NYHLSPRTFPRYPGL | 311 | P41162 | |
| TEYPPLRLTPGHYQR | 4251 | Q86UQ4 | |
| NFGGSPRRAYPTYSP | 736 | Q5JTC6 | |
| GFPPTEPSSTTRAYY | 241 | P56282 | |
| YTPTSRSPQHYSRPG | 376 | Q6H8Q1 | |
| GNYSRPPAYSGVPSA | 921 | Q8NFD5 | |
| FYSGPASPARPRYRL | 321 | Q6PL18 | |
| PRYRLSSAGPRSPYC | 331 | Q6PL18 | |
| YVFGKPFATPTGYRP | 461 | P19835 | |
| FPAYPRSPFQVTAGY | 216 | Q13117 | |
| FPAYPRSPFQVTAGY | 216 | Q9NR90 | |
| ALYYSSSTLPAPPRG | 251 | Q9UQB3 | |
| PRALQPSTAYYPAGT | 581 | Q6NXG1 | |
| TSQSIPTFYFPRGRP | 121 | Q9Y5P8 | |
| LGAPNPTFYSHFPRT | 271 | Q9NXS2 | |
| PFPGGTVLSRPLYYT | 391 | P78411 | |
| SVSPLPRGIYYPEAS | 436 | Q8NAB2 | |
| PPPYRVADSYSNGYR | 766 | Q6GQQ9 | |
| SRTYPYPGTPITQRF | 106 | Q6P3S6 | |
| NPSYGESVYGPSSPR | 301 | Q9Y215 | |
| LAPEGRPYSGPQSSY | 61 | Q6DN12 | |
| FRYTAGTPYKVPPTQ | 101 | Q92567 | |
| NYAPGGTLTRRPYEP | 191 | Q4G1C9 | |
| GPSTPRLYIGRTQYT | 151 | Q76MJ5 | |
| FYSSNIPATARPYRP | 1516 | O75197 | |
| GRYVPPSSTDRSPYE | 1216 | P15941 | |
| TGLYRYPAPSRFPIA | 2256 | Q9UPA5 | |
| QPGYPSSAEYSQPSR | 3696 | Q9UPA5 | |
| NIDPYIYTPFGSGPR | 426 | P08684 | |
| YPSQTTRLPPITYTG | 121 | P18146 | |
| NGYVQSPRFPNSYPR | 61 | Q9GZP0 | |
| DGPRVRYNPYTTRPN | 66 | Q9UBU9 | |
| QLLGSPGRRYYSLPP | 76 | P10515 | |
| PYTNHRTNPGYLLSP | 396 | O00443 | |
| YSGLIPPSFRGVRYV | 151 | Q9NST1 | |
| PTDGPPNSFYRSLYP | 196 | Q9UKB1 | |
| PSRSYSYPRQKTPGT | 646 | Q9H706 | |
| IRYGSRYPTPYGITV | 2271 | P98164 | |
| YPRPPSKTYRGAFQN | 11 | P10275 | |
| SRDYYNFPLALAGPP | 361 | P10275 | |
| GKSPRQSLFFYPSYP | 366 | P15289 | |
| LYRAPVSSLYRTPGP | 726 | Q9UN70 | |
| SSYIPQSRLRYTPHP | 36 | Q9P0J1 | |
| TDPALYSGPFPFYRR | 31 | O77932 | |
| YSGPFPFYRRPSELG | 36 | O77932 | |
| HGDARALRYYSPPPT | 61 | O77932 | |
| YGSFNDSPYKPPVTR | 296 | Q9H7L2 | |
| SCYGNVYNPLPSPSR | 981 | Q9Y2L6 | |
| PGVRYPGTTRVAYLP | 256 | Q8N9I9 | |
| HGSPSRSARVPPFNY | 2261 | O95996 | |
| EPSAPSRPYVVSGYS | 691 | Q9BWV1 | |
| FPAYPRSPFQVTAGY | 546 | Q9NQZ3 | |
| YRPIPAETYVGGTFP | 211 | Q9Y5R5 | |
| YRPYQAPPRATTTTA | 191 | O95500 | |
| SNPPYSLYPRSGTGQ | 271 | Q8TBM8 | |
| TPSIPGFDYRPYIVS | 211 | Q8IW35 | |
| LPNGYPRYPSFGDAS | 146 | Q8WU20 | |
| PFLYSVRRGFNQYPP | 2156 | A8TX70 | |
| GLKQSTYTSSYPRPP | 156 | Q8N1D5 | |
| LFYVPPGRSGPNVYI | 16 | Q30KP9 | |
| RVPKIGPYPDYSSSS | 536 | Q13873 | |
| PEYRYSQSAPGSPVS | 461 | P85037 | |
| TTPGPYRSIYFSSPK | 66 | P29372 | |
| GRHPYAYVPFSAGPR | 451 | Q6ZWL3 | |
| YPASPNGYPRRIQLS | 116 | P22003 | |
| KSNYLRGTGPYPPSV | 106 | P09668 | |
| PGPGHPRTYLTYRRA | 136 | O75064 | |
| SGRAETPQKPPYSYI | 41 | Q12952 | |
| SGYRRETPNLGPYSP | 706 | P11047 | |
| PAPPGASRYSLYTTG | 31 | Q9NT22 | |
| FPAYPRSPFQVTAGY | 381 | Q86SG3 | |
| NIDPYIYTPFGSGPR | 426 | P24462 | |
| RTNPVYRGPYSNPYS | 71 | Q9UBX5 | |
| PTFGPCYINLYGSPR | 516 | O75923 | |
| TLPRNFHYPPDGYSR | 201 | O60716 | |
| TARDYPVYLPHGSPT | 216 | Q9BT04 | |
| SPSPYEGYRSLPRHQ | 351 | Q9UJX0 | |
| GYRVYYTPDSRRPPN | 446 | P10586 | |
| PSEGYRLYPRSPSAV | 151 | Q96BN6 | |
| ASSGLRRPEKPPYSY | 91 | Q12947 | |
| FNTGKPPQDSPYGRY | 236 | Q96FC7 | |
| ISYPPFPGNESNYLR | 471 | Q5TD94 | |
| FSTPGPSTCLPNYYR | 1411 | Q92673 | |
| SPAYISPDVLSGRPY | 236 | Q8N2I9 | |
| YADPYTPPATSHRRV | 456 | Q494U1 | |
| DIPSNSVYRYPPKSG | 16 | Q96PX1 | |
| VPASAYRSVSEPPGY | 341 | Q8IUW3 | |
| YQSRGSPHYFSPFRP | 206 | Q13242 | |
| YRARTPPIINASYGP | 76 | Q14DG7 | |
| PYSPGPRSILYAVLG | 26 | Q96RI9 | |
| SRPGYPSPRSSEGFY | 716 | Q05397 | |
| YTVSPAGADRVPPYR | 1141 | O60292 | |
| PFRGHPTQSPGYSYR | 1261 | Q9C0A6 | |
| GYSYRTTALRPGNPP | 1271 | Q9C0A6 | |
| AEGLYLPATTPYRQP | 111 | Q9P202 | |
| NPYRHTPGSSRANPY | 181 | Q9Y6Y8 | |
| KPRQRESGYYSSPEP | 451 | Q9H093 | |
| HPPGERRAPQYTFGY | 131 | Q8IXM7 | |
| ESSRNYGYNPSPVKP | 1056 | Q15047 | |
| PKSTPTPTYYGSLAR | 1306 | Q9UPV0 | |
| RSAPPLYFPSLYDRG | 16 | Q3C1V1 | |
| VFSRPISASYPPYQA | 141 | Q99816 | |
| YGRPYPFLLQPTAAA | 1091 | O15417 | |
| QPSRGFGYRPPSYST | 156 | O60248 | |
| RAYSQSPRHALYPPS | 571 | Q92738 | |
| PPTYHSGRAFSARYP | 41 | Q8IXZ2 | |
| FYVSRPPLARSSPAY | 806 | Q96PV0 | |
| TGPFRFTPNPEFSTY | 36 | Q969K3 | |
| YARNRPPFGQGYTQP | 381 | Q92734 | |
| AGSQPSSPRYRPYTV | 321 | O95155 | |
| QPVYPITTGGFRHPY | 266 | Q9NQB0 | |
| PGHPPRFLLRYFSQS | 61 | P12018 | |
| PHYGSAFPSISRPQF | 386 | P56693 | |
| PPSYFFGTIHVPYTR | 51 | Q86V40 | |
| YPHAPYLGSARSLSP | 326 | O60504 | |
| EPNYPRSLSNPDYSG | 71 | Q6UXY8 | |
| GAYILPSYPVSSPRT | 811 | Q9Y4F4 | |
| HYSRQYPVFRGRPSG | 36 | Q8NFY4 | |
| RVYLPPLDSGTPNTY | 641 | Q9ULE0 | |
| LPPSSYFNASGRAYP | 436 | O14773 |